BioSpace News Archive

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), today announced that the Company’s novel, once-daily oral and intravenous antibiotic NUZYRA®(omadacycline) has recently been added to the Center for Disease Control and Prevention’s (CDC) updated report, “Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response”.

Walden Biosciences, Inc. (Walden), a biotechnology company focused on transforming the treatment of kidney disease, today announced that Blaine McKee, Ph.D., President and CEO will be presenting at the 41st Annual Canaccord Genuity Virtual Growth Conference.

T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens, announced plans to participate in the upcoming Canaccord Genuity 41st Annual Growth Conference.